![]() | Up a level |
(2023) Behavioral studies of mice with breast cancer after treatment with new anticancer agent, Rh2-containing arginine-graphene. Medicina Balear. pp. 63-65. ISSN 1579-5853
(2022) Evaluating the blood toxicity of functionalized graphene-arginine with anticancer drug ginsenoside Rh2 in balb/c mouse model with breast cancer. Iranian Journal of Pediatric Hematology and Oncology. pp. 10-16. ISSN 2008-8892
(2022) In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer. Iranian Journal of Basic Medical Sciences. pp. 1442-1451. ISSN 2008-3866 (Print) 2008-3874 (Electronic) 2008-3866 (Linking)
(2022) <i>In vivo</i> study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer. Iranian Journal of Basic Medical Sciences. pp. 1442-1451. ISSN 2008-3866